AbCellera Biologics WKN: A2QKXS ISIN: CA00288U1066 Kürzel: ABCL Forum: Aktien Thema: Hauptdiskussion
AbCellera Biologics (ABCL) Truist Financial analyst Srikripa Devarakonda reiterated a Buy rating on AbCellera Biologics today. The company’s shares closed last Wednesday at $2.63. According to TipRanks.com, Devarakonda is a 3-star analyst with an average return of 3.4% and a 47.3% success rate. Devarakonda covers the Healthcare sector, focusing on stocks such as Arvinas Holding Company, Edgewise Therapeutics, and Scholar Rock Holding. The word on The Street in general, suggests a Strong Buy analyst consensus rating for AbCellera Biologics with a $11.50 average price target, representing a 318.2% upside. In a report released today, Bloom Burton also maintained a Buy rating on the stock with a $9.00 price target.
Mehr zu diesem Wert
|
|
Thema | ||
|---|---|---|---|
| 1 | AbCellera Biologics Hauptdiskussion | ||
| 2 | Daytrader ABCellera📈 |
|
|
Thema | ||
|---|---|---|---|
| 1 | RHEINMETALL Hauptdiskussion | -0,01 % | |
| 2 | Diginex | -2,31 % | |
| 3 | NVIDIA Hauptdiskussion | +0,20 % | |
| 4 | Svitzer Group | ±0,00 % | |
| 5 | Critical Metals: Grönland - Tanbreez seltene Erden | +0,28 % | |
| 6 | Dax Prognose | -0,12 % | |
| 7 | Trading- und Aktien-Chat | ||
| 8 | CoinBase (Future ExChange) | +0,54 % | |
| 9 | IRIDIUM COMMUNICATIONS Hauptdiskussion | +0,43 % | |
| 10 | Groupon | -0,40 % | Alle Diskussionen |
|
|
Thema | ||
|---|---|---|---|
| 1 | RHEINMETALL Hauptdiskussion | -0,01 % | |
| 2 | Diginex | -2,31 % | |
| 3 | NVIDIA Hauptdiskussion | +0,20 % | |
| 4 | Svitzer Group | ±0,00 % | |
| 5 | Critical Metals: Grönland - Tanbreez seltene Erden | +0,28 % | |
| 6 | CoinBase (Future ExChange) | +0,54 % | |
| 7 | ATOS Hauptdiskussion | ±0,00 % | |
| 8 | IRIDIUM COMMUNICATIONS Hauptdiskussion | +0,43 % | |
| 9 | ARAFURA RESOURCES Hauptdiskussion | -0,77 % | |
| 10 | FIRST GRAPHENE Hauptdiskussion | ±0,00 % | Alle Diskussionen |